New Executives Join RS21
Mark Epstein, MD, MBA and Matthew Ennis, PhD Expand Leadership, Initiatives at Data Science Company
Now in its eighth year, data science company RS21 is welcoming two new executives to its leadership team. Mark Epstein, MD, MBA and Matthew Ennis, PhD, well known in New Mexico and the broader business community, enter RS21 as Chief Medical Officer and Chief Product and Strategy Officer, respectively. They join Charles Rath, President and CEO, and Melissa Rogers, Chief Operations Officer, as executive leaders.
“We are thrilled to welcome Mark and Matthew to RS21 as we continue evolving our service portfolio and new product arm,” said Charles Rath, RS21 President and CEO. “We have an amazing team developing data technologies focused on helping solve some of the most complex problems we face in healthcare, government and space, and with an expanded executive team, we can continue growing our capabilities and maturing the company.”
Dr. Mark Epstein serves as RS21’s Chief Medical Officer. With more than 20 years of experience as a healthcare executive and physician leader as well as serving in advisory and investor capacities in the healthcare start-up space, Dr. Epstein has dedicated his career to improving health services for better health outcomes.
He most recently served as Advisor for growth stage healthcare IT companies and as CEO and President for True Health New Mexico. In his role at RS21, he will help grow key service areas while also bringing a breadth of experience in business strategy and growth.
Matthew Ennis is Chief Product and Strategy Officer at RS21. A seasoned business executive, investor and entrepreneur with scientific training, Matthew brings experience building enterprise value. In addition to leading strategy, he will oversee RS21’s product development, identifying new opportunities and advancing key RS21 products, like SPAICE for AI-powered satellite fault prediction.
Prior to joining RS21’s executive team, Matthew served as an advisor to RS21’s board and was Chief Strategy Officer for Build With Robots.
RS21 is headquartered in downtown Albuquerque and was founded by Charles Rath in 2015 through Sandia National Laboratories’ Entrepreneurial Separation to Transfer Technology program. Since then, RS21 has grown from a one-person consultancy to a highly technical team that builds data technologies to empower leaders to make data-driven decisions.
RS21 has been an Inc. 5000 fastest-growing company for three consecutive years. It was also named a Fast Company Best Workplace for Innovators in recognition of the Urban Health Vulnerability Index, a free tool the team developed in just five days to help public health officials identify high-risk COVID-19 populations at the height of the pandemic.
About RS21
RS21 is a rapidly growing data science company that uses artificial intelligence, design, data engineering, and modern software development methods to empower organizations to make data-driven decisions that positively impact the world. Our innovative solutions are insightful, intuitive, inspiring, and intellectually honest. With offices in Albuquerque, NM and Washington, DC, RS21 is an Inc. 5000 fastest-growing company three years in a row and a Fast Company Best Workplace for Innovators.
We help clients achieve programmatic goals, improve efficiencies, reduce costs, and maximize productivity using MOTHR, our human-centered, artificial intelligence engine that allows users to seamlessly integrate data and reveal insights at hyper speed. We navigate complex data issues in the fields of healthcare, defense, safety, urban planning, energy, cyber, land use, climate, disaster preparedness, disaster recovery, space, and social equity. For more information, visit http://www.rs21.io.
